Skip to main content
. 2023 Sep 21;24(18):14371. doi: 10.3390/ijms241814371

Figure 1.

Figure 1

Summary of workflow for testing the robustness of 6 COVID-19 diagnostic biomarker panels in an independent quantitative metabolomic and lipidomic LC-MS dataset.